ATLASUpstream Bio (UPB) earnings date: Nov 4, 2026
Upstream Bio (UPB) reports earnings for the quarter ended Sep 30, 2026 on Wed, Nov 4, 2026, before the open. Analysts expect EPS of -$0.67.
Source: company filings and exchange data · Updated Nov 2, 2026
ATLAS view on UPB
| Last price | $3.35 (-1.8%) |
|---|---|
| Normal 1-day range (±1σ) | ±5.7% |
| Earnings beat history | Beat the EPS estimate in 2 of the last 4 reports |
These figures come from the same calibrated model and valuation as the Upstream Bio stock page. They describe an ordinary period, not the earnings reaction itself, which is usually wider and can go either way.
Upstream Bio reports on Nov 4, 2026. One email the day before, with ATLAS’s read on Upstream Bio. You can switch it off at any time.
Alert me before UPB reportsFree to start. Creating an account takes under a minute.
Notify me when Upstream Bio reports
Track UPB free Add Upstream Bio to a free ATLAS watchlist and see its next report date in one place.
UPB earnings at a glance
| Next report (confirmed) | Wed, Nov 4, 2026 |
|---|---|
| Time | Before the open |
| Period | Quarter ended Sep 30, 2026 |
| EPS estimate | -$0.67 |
| Last report | Aug 11, 2026 · Beat |
| Beat rate (last 4 reports) | 2 of 4 (50%) |
| Average EPS surprise | +3.7% |
| Average move around a report | ±3.7% (last 4) |
| Sector | Healthcare · Biotechnology |
Upstream Bio earnings history: last 4 reports
Upstream Bio last reported on Aug 11, 2026: EPS of -$0.73 against an estimate of -$0.76 (+3.9% surprise), a beat.
| Report date | EPS est. | EPS actual | Surprise | Result | Move* |
|---|---|---|---|---|---|
| Aug 11, 2026 | -$0.76 | -$0.73 | +3.9% | Beat | -7.1% |
| Jul 27, 2026 | $1.54 | $1.69 | +9.7% | Beat | -0.2% |
| Jun 17, 2026 | $3.12 | $3.16 | +1.3% | In line | +5.6% |
| May 13, 2026 | -$0.75 | -$0.75 | 0.0% | In line | -1.8% |
*Move: change in the closing price from the last close before the report day to the close the day after it, so it captures the reaction whether the company reported before the open or after the close.
Get the full ATLAS analysis for UPB
See the fair value, the probability range and the earnings history of Upstream Bio on its ATLAS page.
Upstream Bio (UPB) stock analysisPlans from €3.99 a month.
Upstream Bio earnings: frequently asked questions
When does Upstream Bio (UPB) report earnings?
Upstream Bio is scheduled to report on Wednesday, November 4, 2026, before the open. ATLAS only shows a confirmed date when the company or the exchange data provides one; check the investor relations page for the call details.
What is the EPS estimate for UPB?
The consensus EPS estimate for the quarter ended Sep 30, 2026 is -$0.67 per share (USD). Estimates can change before the report.
How often does UPB beat earnings estimates?
Of its last 4 reports with a recorded result, Upstream Bio beat the EPS estimate 2 times; the average surprise was +3.7%. Past results do not predict the next one.
How much does UPB move around earnings?
Over its last 4 reports the stock moved an average of 3.7% (absolute, from the close before the report day to the close after it), and finished higher 1 of 4 times.
Did Upstream Bio beat earnings estimates last quarter?
Upstream Bio last reported on Aug 11, 2026: EPS of -$0.73 against an estimate of -$0.76 (+3.9% surprise), a beat.
How much does UPB usually move in a day?
On a normal trading day the ATLAS model puts UPB’s one-day range at about ±5.7%, with a 49% chance of closing higher. This is not an options-implied earnings move; earnings days are usually wider.
Also reporting on Wed, Nov 4, 2026
Educational information, not investment advice. Disclaimer